Showing results (251-260 of 274) with videos related to

Sort By:
Pageof 28
BMC Medicine|April 5, 2022
Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm studyLugui Qiu, Zhongjun Xia, Chengcheng Fu, et al.
Acta Crystallographica. Section D, Biological Crystallography|December 14, 2006
Crystallization of protein-ligand complexesAnne M Hassell, Gang An, Randy K Bledsoe, et al.
Blood Advances|October 10, 2019
The impact of response kinetics for multiple myeloma in the era of novel agentsYuting Yan, Xuehan Mao, Jiahui Liu, et al.
Blood Cancer Journal|November 5, 2020
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivoTengteng Yu, Bharat Chaganty, Liang Lin, et al.
Blood Advances|May 10, 2022
Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WMJun Wang, Yuting Yan, Wenjie Xiong, et al.
Journal of Bone Oncology|December 9, 2024
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jawHan-Jin Ruan, Heng Chen, Jin-Song Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2024
Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström MacroglobulinemiaYuting Yan, Ying Yu, Wenjie Xiong, et al.
Haematologica|October 9, 2025
Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 studyGang An, Jie Jin, Zhen Cai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2015
The impact of clone size on the prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myelomaGang An, Zengjun Li, Yu-Tzu Tai, et al.
Leukemia|October 9, 2019
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myelomaGang An, Yuting Yan, Yan Xu, et al.
Pageof 28